Extracorporeal Membrane Oxygenation (ECMO) and its complications in newborns with congenital diaphragmatic hernia.


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 21 05 2021
revised: 19 12 2021
accepted: 23 12 2021
pubmed: 24 1 2022
medline: 20 7 2022
entrez: 23 1 2022
Statut: ppublish

Résumé

Extracorporeal Membrane Oxygenation (ECMO) is offered to patients with congenital diaphragmatic hernia (CDH) who are in severe respiratory and cardiac failure. We aim to describe the types of complications among these patients and their impact on survival. A single-center, retrospective review of CDH patients cannulated onto ECMO between January 2005 and November 2020 was conducted. ECMO complications, as categorized by the Extracorporeal Life Support Organization (ELSO), were correlated with survival status. Descriptive statistics were used to compare observed complications between survivors and non-survivors. In our cohort of CDH neonates, 21% (54/258) were supported with ECMO, of whom, 61% (33/54) survived. Survivors and non-survivors were similar in baseline characteristics except for birthweight z-score (p = 0.043). Seventy percent of CDH neonates experienced complications during their ECMO run, with the most common categories being metabolic (48.1%) and mechanical (38.9%), followed by hemorrhage (22.2%), neurological (18.5%), renal (11.1%), pulmonary (7.4%), and cardiovascular (7.4%). The median number of complications per patient was higher in the non-survivor group  (2 (IQR: 1-4) vs 1 (IQR: 0-2), p = 0.043). In addition, mechanical (57.1% vs 27.3%, p = 0.045) and renal (28.6% vs 0%, p = 0.002) complications were more common among non-survivors compared to survivors. Complications occur frequently among ECMO-treated newborns with CDH, some of which have serious long-term consequences. Survivors had higher birth weight z-scores, shorter ECMO runs, and fewer complications per patient. Mechanical and renal complications were independently associated with mortality, emphasizing the utility of more focused strategies to target fluid balance and renal protection and to prevent circuit and cannula complications.

Sections du résumé

BACKGROUND BACKGROUND
Extracorporeal Membrane Oxygenation (ECMO) is offered to patients with congenital diaphragmatic hernia (CDH) who are in severe respiratory and cardiac failure. We aim to describe the types of complications among these patients and their impact on survival.
METHODS METHODS
A single-center, retrospective review of CDH patients cannulated onto ECMO between January 2005 and November 2020 was conducted. ECMO complications, as categorized by the Extracorporeal Life Support Organization (ELSO), were correlated with survival status. Descriptive statistics were used to compare observed complications between survivors and non-survivors.
RESULTS RESULTS
In our cohort of CDH neonates, 21% (54/258) were supported with ECMO, of whom, 61% (33/54) survived. Survivors and non-survivors were similar in baseline characteristics except for birthweight z-score (p = 0.043). Seventy percent of CDH neonates experienced complications during their ECMO run, with the most common categories being metabolic (48.1%) and mechanical (38.9%), followed by hemorrhage (22.2%), neurological (18.5%), renal (11.1%), pulmonary (7.4%), and cardiovascular (7.4%). The median number of complications per patient was higher in the non-survivor group  (2 (IQR: 1-4) vs 1 (IQR: 0-2), p = 0.043). In addition, mechanical (57.1% vs 27.3%, p = 0.045) and renal (28.6% vs 0%, p = 0.002) complications were more common among non-survivors compared to survivors.
CONCLUSION CONCLUSIONS
Complications occur frequently among ECMO-treated newborns with CDH, some of which have serious long-term consequences. Survivors had higher birth weight z-scores, shorter ECMO runs, and fewer complications per patient. Mechanical and renal complications were independently associated with mortality, emphasizing the utility of more focused strategies to target fluid balance and renal protection and to prevent circuit and cannula complications.

Identifiants

pubmed: 35065805
pii: S0022-3468(22)00006-9
doi: 10.1016/j.jpedsurg.2021.12.028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1642-1648

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None

Auteurs

Latoya A Stewart (LA)

Columbia University Vagelos College of Physicians and Surgeons, 630W 168th Street, New York, NY 10032, United States.

Rafael Klein-Cloud (R)

Division of Pediatric Surgery, NewYork Presbyterian-Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, 3959 Broadway, 2nd Floor, New York, NY 10032, United States.

Claire Gerall (C)

Division of Pediatric Surgery, NewYork Presbyterian-Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, 3959 Broadway, 2nd Floor, New York, NY 10032, United States.

Weijia Fan (W)

Department of Biostatistics, Columbia University Mailman School of Public Health, 722W 168th Street, New York, NY 10032, United States.

Jessica Price (J)

Division of Pediatric Surgery, NewYork Presbyterian-Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, 3959 Broadway, 2nd Floor, New York, NY 10032, United States.

Rebecca R Hernan (RR)

Department of Pediatrics, NewYork Presbyterian-Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, 3959 Broadway, 2nd Floor, New York, NY 10032, United States.

Usha S Krishnan (US)

Department of Pediatrics, NewYork Presbyterian-Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, 3959 Broadway, 2nd Floor, New York, NY 10032, United States.

Eva W Cheung (EW)

Department of Pediatrics, NewYork Presbyterian-Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, 3959 Broadway, 2nd Floor, New York, NY 10032, United States.

William Middlesworth (W)

Division of Pediatric Surgery, NewYork Presbyterian-Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, 3959 Broadway, 2nd Floor, New York, NY 10032, United States.

Diana Vargas Chaves (DV)

Department of Pediatrics, NewYork Presbyterian-Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, 3959 Broadway, 2nd Floor, New York, NY 10032, United States.

Russell Miller (R)

Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, 622W 168th Street, PH 16, New York, NY 10032, United States.

Lynn L Simpson (LL)

Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, 622W 168th Street, PH 16, New York, NY 10032, United States.

Wendy K Chung (WK)

Department of Pediatrics, NewYork Presbyterian-Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, 3959 Broadway, 2nd Floor, New York, NY 10032, United States.

Vincent P Duron (VP)

Division of Pediatric Surgery, NewYork Presbyterian-Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, 3959 Broadway, 2nd Floor, New York, NY 10032, United States. Electronic address: vd2312@cumc.columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH